1. All patients were operated on after traumatic femoral neck fracture. Those patients with previous instrumentation of the femoral canal were excluded. 2. A cement gun is routinely used at our centre. Although there may have been isolated cases where 'finger packing' was used, the absolute majority of procedures were done with cement gun. Unfortunately, we do not have data on the exact number of patients in whom the cement gun was used or not used.
3. Vacuum mixing is routinely used at our centre. 4 . We do not have data on the incidence of osteoporosis from DEXA screening or the use of anti-osteoporotic drugs in our study group. As our patient material consisted of predominantly elderly patients with a mean age of 85 yr, and that fractured femoral neck is a typical injury seen in osteoporosis, we can assume that the majority of patients had osteoporosis to some degree.
Declaration of interest
None declared. Among >280 000 admissions to 203 ICU's in the UK reporting data to the Intensive Care National Audit and Research Center (ICNARC), unit acquired bacteremia occurred in 2.7 percent of ICU admissions for nine ICUs that were using SDD vs 2.8 percent for 196 that were not. 1 These findings are similar to those in a nation-wide survey of 19 Dutch ICUs, amongst which the bacteremia rates were 5 vs 4 per 100 patient days for ICUs using vs not using SDD, respectively. 2 The findings in these surveys contrast to the findings of published randomized concurrent control trials (RCCT) of SDD as summarized in two meta-analyses, which indicate an apparent reduction in bacteremia as great as 31%. 3 4 Moreover, in a sub-analysis of the UK survey, the nine ICUs using SDD includes three that were using SDD with an i.v. component, for which the bacteremia rates was 0.1%. The bacteremia rate amongst the other six ICUs that were using SDD without an i.v. component is unknown but presumably higher than 2.7%.
Critical to the interpretation of both the UK and the Dutch survey findings is clarifying whether the bacteremia rates as reported by the units was for the entire unit and not limited to those patients receiving SDD for those units that reported use of SDD.
The apparent effect of SDD regardless of formulation and components requires a cautious interpretation and more information is needed in this regard to determine the direct vs indirect (contextual) contributions toward the apparent effect of SDD in the survey. [4] [5] [6] [7] In contrast to the survey findings, among published randomized concurrent control trials (RCCT) of SDD, the mean bacteremia and VAP incidences are unusually high for the control groups. [5] [6] [7] For the incidence of bacteremia this is as much as twofold higher vs groups within studies of comparable populations, either without any study intervention, or studies with a nonantibiotic method of intervention. The incidences among concurrent control groups of SDD studies are higher than that among studies of SDD for which the control group was either non-concurrent or concurrent and receiving only the i.v. component of SDD. Presumably, the i.v. component mitigates against this risk. Underlying this discrepancy is a selective increase in coagulase negative staphylococci (CNS), but not in Pseudomonas aeruginosa among bacteremia isolates within concurrent control groups of SDD-RCCT's vs benchmark groups with data available.
A selective increase in Staphylococcus aureus among concurrent control group patients, partially accounts for the increase in VAP rates as a contextual effect of SDD.
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I ask Canter and colleagues whether their survey findings may have a different interpretation. Is it possible that through a contextual effect, SDD, regardless of formulation, increases the risk of VAP and bacteremia infection for patients concurrently located in the ICU and not receiving SDD. 7 In this regard, are the bacteremia rates among the units using SDD without an i.v. component known? Is the proportion of bacteremia isolates that were coagulase negative staphylococci (CNS) and Pseudomonas aeruginosa known for units using vs units not using SDD known? With this information it would be possible to determine how much of the differences seen in the survey results represent a direct effect of SDD in recipients vs indirect or contextual effects of SDD in collocated ICU patients.
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Editor-We thank Dr Hurley for his interest in our study. 1 The finding in other studies of unusually high bacteraemia and ventilator-associated pneumonia (VAP) rates in control group patients is interesting. We investigated the use of selective decontamination of the digestive tract (SDD) in UK critical care and compared patient outcomes in units that do and do not report using SDD. We did not, however, collect information about SDD use at a patient level and so cannot draw any conclusions on the risk of VAP and bacteraemia infection in patients who did not receive SDD within a unit that routinely uses SDD. The rate of unit-acquired infections in blood in the six units that reported using SDD, without an i.v. component, was 4.1% (168/4078), which was higher than the rates observed in both the three SDD units that included an i.v. component (0.1%) and the 196 non-SDD units (2.1%). However, these results should be interpreted cautiously given the small number of units that reported using SDD. Furthermore, this was a non-randomized comparison and although we controlled for differences in case mix, the risk of residual confounding cannot be excluded.
The analysis comparing patient outcomes was based on existing data from a high quality clinical database. Coagulase negative staphylococci isolates in blood are not recorded as bacteraemia, as these are usually contaminants. Of the 170 bacteraemias reported in the nine SDD units, 13 (7.6%) were reported as having had a Pseudomonas species isolated in the blood compared with 426 (10.2%) out of the 4168 bacteraemias reported by the 196 non-SDD units. The specific species of isolates in blood were not reported.
In summary, our results are suggestive of cautious support for the benefits of SDD in potentially reducing bacteraemia (when the i.v. component is adopted). The impact of SDD on other outcomes was less apparent, with no demonstrable benefit observed on mortality. Data on use of SDD was collected at a unit level only in our study, so we are unable to draw any conclusions on the direct effect of SDD in recipients compared with the indirect or contextual effects in patients who did not receive SDD.
